Concepedia

Publication | Closed Access

Phase II trial of subcutaneously administered granulocyte-macrophage colony-stimulating factor in patients with metastatic renal cell carcinoma.

26

Citations

27

References

1996

Year

E Wos, T Olencki, Laurie Tuason, G. Thomas Budd, D. Peereboom, Kate Sandstrom, D McLain, James H. Finke, Ronald M. Bukowski
PubMed

Abstract

GM-CSFrh may mediate tumor regression in patients with metastatic RCC; however, the level of activity in previously treated patients is low.

References

YearCitations

Page 1